Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Charlton

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical Medicine (London, England)|August 31, 2012
A medical classic: Liza of LambethRodger Charlton, Peter Charlton
BMC Cancer|January 7, 2017
Molecular chess? Hallmarks of anti-cancer drug resistanceIan A Cree, Peter Charlton
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 9, 2015
Optimising the Windkessel model for cardiac output monitoring during changes in vascular tonePeter Charlton, John Smith, Luigi Camporota, et al.
IEEE Journal of Biomedical and Health Informatics|July 29, 2014
Signal-quality indices for the electrocardiogram and photoplethysmogram: derivation and applications to wireless monitoringChristina Orphanidou, Timothy Bonnici, Peter Charlton, et al.
Healthcare Technology Letters|March 19, 2019
Estimation of respiratory rate from motion contaminated photoplethysmography signals incorporating accelerometryDelaram Jarchi, Peter Charlton, Marco Pimentel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexesLindsay J Marshall, Lara S P Ramdin, Teresa Brooks, et al.
Cancer Chemotherapy and Pharmacology|August 6, 2008
Effect of phenazine compounds XR11576 and XR5944 on DNA topoisomerasesAndrew G Jobson, Elaine Willmore, Michael J Tilby, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 2017
Identifying Hemodynamic Determinants of Pulse Pressure: A Combined Numerical and Physiological ApproachSamuel Vennin, Ye Li, Marie Willemet, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Structure-activity relationships for analogues of the phenazine-based dual topoisomerase I/II inhibitor XR11576Shouming Wang, Warren Miller, John Milton, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Novel inhibitors of plasminogen activator inhibitor-1: development of new templates from diketopiperazinesShouming Wang, Julian Golec, Warren Miller, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Medicine (London, England)|August 31, 2012
A medical classic: Liza of LambethRodger Charlton, Peter Charlton
BMC Cancer|January 7, 2017
Molecular chess? Hallmarks of anti-cancer drug resistanceIan A Cree, Peter Charlton
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 9, 2015
Optimising the Windkessel model for cardiac output monitoring during changes in vascular tonePeter Charlton, John Smith, Luigi Camporota, et al.
IEEE Journal of Biomedical and Health Informatics|July 29, 2014
Signal-quality indices for the electrocardiogram and photoplethysmogram: derivation and applications to wireless monitoringChristina Orphanidou, Timothy Bonnici, Peter Charlton, et al.
Healthcare Technology Letters|March 19, 2019
Estimation of respiratory rate from motion contaminated photoplethysmography signals incorporating accelerometryDelaram Jarchi, Peter Charlton, Marco Pimentel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexesLindsay J Marshall, Lara S P Ramdin, Teresa Brooks, et al.
Cancer Chemotherapy and Pharmacology|August 6, 2008
Effect of phenazine compounds XR11576 and XR5944 on DNA topoisomerasesAndrew G Jobson, Elaine Willmore, Michael J Tilby, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 2017
Identifying Hemodynamic Determinants of Pulse Pressure: A Combined Numerical and Physiological ApproachSamuel Vennin, Ye Li, Marie Willemet, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Structure-activity relationships for analogues of the phenazine-based dual topoisomerase I/II inhibitor XR11576Shouming Wang, Warren Miller, John Milton, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Novel inhibitors of plasminogen activator inhibitor-1: development of new templates from diketopiperazinesShouming Wang, Julian Golec, Warren Miller, et al.
Pageof 3